Thyroid Disfunction in Critically Ill COVID-19 Patients. Relationship with In-Hospital Mortality
- PMID: 34768580
- PMCID: PMC8584356
- DOI: 10.3390/jcm10215057
Thyroid Disfunction in Critically Ill COVID-19 Patients. Relationship with In-Hospital Mortality
Abstract
The incidence of thyroid disfunction has not been analyzed in critically ill COVID-19 patients. Our objective was to analyze the relationship of the thyroid profile and in-hospital mortality in critically ill COVID-19 patients. This was a prospective single-center study involving critically ill COVID-19 patients admitted to the ICU of a tertiary University Hospital. Thyroid hormones were measured through drawing blood samples from a central venous catheter at ICU admission and on the fifth day. A multiple logistic regression analysis was performed to analyze the variables associated with mortality. The ability of the different thyroid hormones to predict in-hospital mortality was evaluated by calculating the receiver operating characteristics (ROCs) and the area under the curve (AUC). A total of 78 patients were included in the study at ICU admission; 72 had their thyroid profile measured at day 5. In-hospital mortality reached 29.5%. Multiple logistic regression analysis showed that variables associated with mortality were age and prior beta-blocker therapy at ICU admission and age fT4 at day 5. The AUC for in-hospital mortality predictions of fT4 at day 5 was 0.69. Thyroid responses are commonly observed in critically ill COVID-19 patients. fT4 at day 5 after ICU admission was associated with mortality.
Keywords: COVID-19; critically ill patients; intensive care unit; mortality; thyroid hormones.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
Grants and funding
LinkOut - more resources
Full Text Sources